In addition, a previous study reported that BAP18 is upregulated in NSCLC tissues and promotes tumor cell proliferation by transcriptionally activating CCND1 and CCND2, suggesting a potential oncogenic role (30). Here, CCND2 is linked to non-small cell lung carcinoma.